The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design
Stewart Coats, Andrew J., Srinivasan, Venkatesan, Surendran, Jayaraman, Chiramana, Haritha, Vangipuram, Shankar R. K. G., Bhatt, Nirajkumar N., Jain, Minish, Shah, Sandip, Ali, Irfhan A. B. H., Fuang, Ho G., Hassan, Mohammed Z. M., Beadle, John, Tilson, Julia, Kirwan, Bridget-Anne, Anker, Stefan D.
Published in Journal of cachexia, sarcopenia and muscle (01.12.2011)
Published in Journal of cachexia, sarcopenia and muscle (01.12.2011)
Get full text
Journal Article
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer
Stewart Coats, Andrew J., Srinivasan, Venkatesan, Surendran, Jayaraman, Chiramana, Haritha, Vangipuram, Shankar R. K. G., Bhatt, Nirajkumar N., Jain, Minish, Shah, Sandip, Ali, Irfhan A. B. H., Fuang, Ho G., Hassan, Mohammed Z. M., Beadle, John, Tilson, Julia, Kirwan, Bridget-Anne, Anker, Stefan D.
Published in Journal of cachexia, sarcopenia and muscle (01.12.2011)
Published in Journal of cachexia, sarcopenia and muscle (01.12.2011)
Get full text
Journal Article